Back to results
Bibliographic record · Consultation and access
Artículo

Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?

Seremeta, Katia Pamela et al · Elsevier Science · 2019

Supplementary material available
Quick overview. Review the resource’s basic details, then access the content using the main button. This page shows only the information needed to identify, cite, and open the work.

Resource access

Open the content from the main option or choose another available source.

CONICET Digital CONICET Digital OAI-PMH
Entrar por CONICET Digital
Main access

Supplementary material available

El enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Open material

Summary

Descripción general del contenido del recurso.

Benznidazole (BNZ) is the drug of choice for the treatment of Chagas disease in many countries. However, its low water solubility produces low and/or variable oral bioavailability. Thus, the aim of this work was to formulate micro- and nanoparticles based on Eudragit® RS PO and Eudragit® RL PO as a convenient approach to increase the dissolution rate of BNZ. The microparticles were obtained by means of spray-drying process while the nanoparticles were prepared through the nanoprecipitation technique and further freeze-drying. The results indicated that nanoparticles were obtained in 86% yield while microparticles were obtained in 68% yield. In both cases, the encapsulation efficiency of particles was greater than 78% while drug loading capacity was nearly 24% w/w and 18% w/w, after spray-drying and freeze-drying procedures, respectively. Images of scanning electron microscopy showed that the particles obtained by spray-drying and freeze-drying were in the micrometer and nanometer scale, respectively. FT-IR spectra of BNZ-loaded particles obtained by both methods showed characteristic bands of BNZ confirming that part of drug remained on their surface. Thermal analysis revealed that the drug crystallinity after both methods decreased. Physical stability evaluation of the nanoparticles confirmed that Pluronic® F68 was suitable to keep the particles size in a range of 300 nm after 70 days storage at 4 ± 2 °C. In-vitro release studies showed increased dissolution rate of drug from the particles obtained by both methods respect to untreated BNZ. The kinetics of drug release in acid media followed the Higuchi kinetics indicating drug diffusion mechanism from particles. Fil: Seremeta, Katia Pamela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina. Universidad Nacional del Chaco Austral. Departamento de Ciencias Básicas y Aplicadas; Argentina Fil: Arrua, Eva Carolina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Química Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Química Rosario; Argentina

How to cite

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

Seremeta, K. P. E. A. (2019). Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?. http://hdl.handle.net/11336/108136

MLA

Seremeta, Katia Pamela et al. "Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?." 2019. http://hdl.handle.net/11336/108136.

Chicago

Seremeta, Katia Pamela et al. 2019. "Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?.". http://hdl.handle.net/11336/108136.

Harvard

Seremeta, K. P. E. A. 2019, Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?, Elsevier Science, available at: http://hdl.handle.net/11336/108136 [Accessed 10 Aug. 2026].

Share and print

Save the record, copy its permanent link, or print it as a PDF.

Export reference

You can export the record in common formats for use in a reference manager.

Resource details

Bibliographic information to help confirm that this is the correct material.

Title
Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?
Author / contributors
Seremeta, Katia Pamela et al
Publisher
Elsevier Science
Publication year
2019
ISSN
0927-7765
ISSN
0927-7765
Language
English

Subjects

Explore related resources through these subjects.

Copied